Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNE.L Regulatory News (HNE)

  • There is currently no data for HNE

Share Split and Total Voting Rights

6 Oct 2021 10:32

RNS Number : 2129O
Henderson Eurotrust PLC
06 October 2021
 

HENDERSON INVESTMENT FUNDS LIMITED

 

HENDERSON EUROTRUST PLC

 

LEGAL ENTITY IDENTIFIER: 213800DAFFNXRBWOEF12

 

 

6 October 2021

 

HENDERSON EUROTRUST PLC

Share Split and Total Voting Rights

 

Henderson EuroTrust plc (the 'Company') today announces further details of the announced sub-division (the 'Share Split') of each ordinary share of 5p each ('Existing Ordinary Share') into 10 ordinary shares of 0.5p each ('New Ordinary Shares'), subject to the approval of the Share Split at the Company's Annual General Meeting ('AGM'), which will be held on 17 November 2021.

 

The Share Split is also conditional on the New Ordinary Shares being admitted to the Official List of the Financial Conduct Authority ('FCA') and to trading on the London Stock Exchange's main market for listed securities. Applications for such admissions (the 'Admission Applications') are being made and it is expected that such admissions will become effective, and that dealings in the New Ordinary Shares will commence, at 8.00am on Monday 22 November 2021, at which time the Share Split will become effective. The last day of trading in the Existing Ordinary Shares is expected to be, therefore, Friday 19 November 2021 and the record date for the Share Split is 5.00pm on that date (the 'Record Date').

 

Shareholders will receive 10 New Ordinary Shares in exchange for each Existing Ordinary Share held at the Record Date. CREST accounts are expected to be credited with New Ordinary Shares on Monday 22 November 2021 and share certificates in respect of the New Ordinary Shares are expected to be posted to shareholders no later than Friday 26 November 2021.

 

The New Ordinary Shares will have a new ISIN and SEDOL, as follows:

 

New ISIN: GB00BP6QR382

New SEDOL: BP6QR38

 

The ticker for the New Ordinary Shares will remain the same as the ticker for the Existing Ordinary Shares (HNE). The New Ordinary Shares will rank pari passu with each other and will be subject to the same rights and restrictions as the Existing Ordinary Shares. Each New Ordinary Share will also have one vote per share on a poll. A holding of New Ordinary Shares following the Share Split will represent the same proportion of the issued ordinary share capital of the Company as the corresponding holding of Existing Ordinary Shares immediately prior to the Share Split.

 

The Company currently has 21,205,541 Existing Ordinary Shares in issue (20,000 Existing Ordinary Shares are held in treasury). On this basis, in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6, the Company advises that, following the completion of the Share Split, as at Monday 22 November 2021 the Company will have 212,055,410 New Ordinary Shares in issue (200,000 New Ordinary Shares would be held in treasury) (assuming no further shares are issued by the Company prior to the Share Split).

 

The Admission Applications include the 204,527 Existing Ordinary Shares remaining available for issue pursuant to the Company's current block listing facility. Upon the Share Split becoming effective, there will be 204,527 New Ordinary Shares available for issue pursuant to that facility (assuming no further shares are issued by the Company prior to the Share Split).

 

 

 

For further information please contact:

 

James de Sausmarez

Director and Head of Investment Trusts

Henderson Investment Funds Limited

Telephone: 020 7818 3349

 

Laura Thomas

PR Manager, Investment Trusts

Janus Henderson Investors

Telephone: 020 7818 2636

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFFAIALRIIL
Date   Source Headline
25th Oct 202311:47 amRNSNet Asset Value(s)
24th Oct 202312:09 pmRNSNet Asset Value(s)
23rd Oct 202312:24 pmRNSNet Asset Value(s)
23rd Oct 202310:51 amRNSMonthly Factsheet as at 30 September 2023
20th Oct 202312:05 pmRNSNet Asset Value(s)
19th Oct 202312:44 pmRNSNet Asset Value(s)
18th Oct 202311:49 amRNSNet Asset Value(s)
17th Oct 202312:01 pmRNSNet Asset Value(s)
16th Oct 20233:10 pmRNSNet Asset Value(s)
13th Oct 20231:02 pmRNSNet Asset Value(s)
12th Oct 202312:17 pmRNSNet Asset Value(s)
11th Oct 202312:07 pmRNSNet Asset Value(s)
10th Oct 202312:41 pmRNSNet Asset Value(s)
9th Oct 20233:24 pmRNSNet Asset Value(s)
6th Oct 202312:29 pmRNSNet Asset Value(s)
5th Oct 202311:42 amRNSNet Asset Value(s)
5th Oct 20239:44 amRNSAnnual Report and Financial Statements
4th Oct 202312:21 pmRNSNet Asset Value(s)
3rd Oct 202312:31 pmRNSNet Asset Value(s)
2nd Oct 20232:35 pmRNSNet Asset Value(s)
28th Sep 202312:00 pmRNSNet Asset Value(s)
28th Sep 20237:00 amRNSAnnual Financial Report
27th Sep 202312:26 pmRNSNet Asset Value(s)
26th Sep 202312:37 pmRNSNet Asset Value(s)
25th Sep 20234:58 pmRNSHolding(s) in Company
25th Sep 20233:25 pmRNSNet Asset Value(s)
22nd Sep 202312:40 pmRNSNet Asset Value(s)
21st Sep 20232:59 pmRNSMonthly Factsheet as at 31 August 2023
21st Sep 202312:10 pmRNSNet Asset Value(s)
20th Sep 202312:25 pmRNSNet Asset Value(s)
19th Sep 202311:55 amRNSNet Asset Value(s)
18th Sep 20233:28 pmRNSNet Asset Value(s)
15th Sep 202312:37 pmRNSNet Asset Value(s)
14th Sep 202312:44 pmRNSNet Asset Value(s)
13th Sep 202312:30 pmRNSNet Asset Value(s)
12th Sep 202312:11 pmRNSNet Asset Value(s)
11th Sep 20233:12 pmRNSNet Asset Value(s)
8th Sep 20231:06 pmRNSNet Asset Value(s)
7th Sep 20233:51 pmRNSHolding(s) in Company
7th Sep 20231:06 pmRNSNet Asset Value(s)
5th Sep 202311:17 amRNSNet Asset Value(s)
4th Sep 20232:52 pmRNSNet Asset Value(s)
1st Sep 20231:05 pmRNSNet Asset Value(s)
1st Sep 202311:56 amRNSHolding(s) in Company
31st Aug 202310:57 amRNSNet Asset Value(s)
30th Aug 202312:33 pmRNSNet Asset Value(s)
29th Aug 20232:34 pmRNSNet Asset Value(s)
25th Aug 202312:08 pmRNSNet Asset Value(s)
24th Aug 20231:09 pmRNSNet Asset Value(s)
23rd Aug 20231:04 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.